(Q36248058)

13 August 2017

1 reference

title

Mechanistic connections between glucose/lipid disturbances and weight gain induced by antipsychotic drugs (English)

1 reference

13 August 2017

1 reference

Donard S Dwyer

1

1 reference

13 August 2017

Dallas Donohoe

series ordinal

2

1 reference

13 August 2017

Xiao-Hong Lu

series ordinal

3

1 reference

13 August 2017

Eric J Aamodt

series ordinal

4

1 reference

13 August 2017

publication date

1 January 2005

1 reference

International Review of Neurobiology

13 August 2017

published in

1 reference

13 August 2017

volume

65

1 reference

13 August 2017

page(s)

211-247

1 reference

Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Development of an atherogenic metabolic risk factor profile associated with the use of atypical antipsychotics.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Consensus development conference on antipsychotic drugs and obesity and diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Inhibition of glucose transport in PC12 cells by the atypical antipsychotic drugs risperidone and clozapine, and structural analogs of clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Tissue concentrations of clozapine and its metabolites in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Metformin in obesity associated with antipsychotic drug administration: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Long term administration of some antipsychotic drugs increases body weight and feeding in rats. Are D2 dopamine receptors involved?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

759C/T genetic variation of 5HT(2C) receptor and clozapine-induced weight gain

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

K(ATP) channels: linker between phospholipid metabolism and excitability

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Serum glucose and lipid changes during the course of clozapine treatment: the effect of concurrent beta-adrenergic antagonist treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Glucokinase mutations, insulin secretion, and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Induction of obesity by psychotropic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Weight gain associated with psychotropic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Differential effect of clozapine on weight: a controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

The AMP-activated protein kinase cascade--a unifying system for energy control

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Differences between antipsychotic drugs in persistence of brain levels and behavioral effects

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Weight gain associated with clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Pharmacogenetics of antipsychotic-induced weight gain

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Appetite suppression by commonly used drugs depends on 5-HT receptors but not on 5-HT availability

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Antipsychotic-induced weight gain and therapeutic response: a differential association.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

An update on type 2 diabetes in youth from the National Diabetes Education Program

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Psychoactive drugs affect glucose transport and the regulation of glucose metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Induction of hyperglycemia in mice with atypical antipsychotic drugs that inhibit glucose uptake

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Dopamine receptor antagonists modulate glucose uptake in rat pheochromocytoma (PC12) cells

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Antipsychotic drugs affect glucose uptake and the expression of glucose transporters in PC12 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

The pancreatic beta-cell glucose sensor.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

CYP2D6 polymorphisms and atypical antipsychotic weight gain.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

The human beta 3-adrenoceptor: the search for a physiological function

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

The structural and biochemical basis of movement disorders in treatment with neuroleptic drugs and in extrapyramidal diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Estimating the consequences of anti-psychotic induced weight gain on health and mortality rate

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Hyperleptinemia, visceral adiposity, and decreased glucose tolerance in mice with a targeted disruption of the histidine decarboxylase gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Serum triglyceride levels in patients treated with clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

WEIGHT CHANGE DURING AND AFTER HOSPITAL TREATMENT.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

H(1)-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Olanzapine: weight gain and therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Protein kinase B (PKB/Akt)--a key regulator of glucose transport?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Management of cellular energy by the AMP-activated protein kinase system

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Effects of clozapine, olanzapine and haloperidol on the microstructure of ingestive behaviour in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Serotonergic and histaminergic mechanisms involved in intralipid drinking?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Plasma leptin and adiposity during antipsychotic treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Schizophrenia and diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Genetic variant of the histamine-1 receptor (glu349asp) and body weight change during clozapine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Genetic variants of the serotonin system and weight change during clozapine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Type 2 diabetes in the young: the evolving epidemic: the international diabetes federation consensus workshop

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Hypertriglyceridemia: associated risks and effect of drug treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Drug-induced weight gain

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Interrelationship and control of glucose metabolism and lipogenesis in isolated fat-cells. Control of pentose phosphate-cycle activity by cellular requirement for reduced nicotinamide adenine dinucleotide phosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Studies on modulation of feeding behavior by atypical antipsychotics in female mice

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Weight gain in adolescents treated with risperidone and conventional antipsychotics over six months

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Ziprasidone suppresses olanzapine-induced increases in ingestive behaviour in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Inhibition by various antipsychotic drugs of the G-protein-activated inwardly rectifying K(+) (GIRK) channels expressed in xenopus oocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Olanzapine-associated diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Clozapine-associated diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Persistence of haloperidol in human brain tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

An assessment of the independent effects of olanzapine and risperidone exposure on the risk of hyperlipidemia in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Lipoprotein abnormalities and their consequences for patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Clozapine-induced weight gain: prevalence and clinical relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

CNS sensing and regulation of peripheral glucose levels

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Olanzapine produces trophic effects in vitro and stimulates phosphorylation of Akt/PKB, ERK1/2, and the mitogen-activated protein kinase p38.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Involvement of hypothalamic histamine H1 receptor in the regulation of feeding rhythm and obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Targeted disruption of histamine H1-receptor attenuates regulatory effects of leptin on feeding, adiposity, and UCP family in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Essential biochemical design features of the fuel-sensing system in pancreatic beta-cells

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

C elegans: a model for exploring the genetics of fat storage

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Insulin and leptin levels in patients with schizophrenia or related psychoses--a comparison between different antipsychotic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

The role of serotonin in antipsychotic drug action

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Clozapine-induced weight gain predicts improvement in psychopathology

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Novel antipsychotics and severe hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

The effects of antipsychotic therapy on serum lipids: a comprehensive review.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Serum triglycerides, the liver and the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Tissue-specific ablation of the GLUT4 glucose transporter or the insulin receptor challenges assumptions about insulin action and glucose homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Akt mediates the cross-talk between beta-adrenergic and insulin receptors in neonatal cardiomyocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Metformin for weight loss in pediatric patients taking psychotropic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Insulin action impaired by deficiency of the G-protein subunit G ialpha2

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Pharmacogenetics of antipsychotic-induced weight gain

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Possible association between tardive dyskinesia and altered carbohydrate metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Chlorpromazine and related phenothiazines inhibit the ATP-sensitive K+ channel

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

New insights into sympathetic regulation of glucose and fat metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Glycemic effects of chlorpromazine in the mouse, hamster and rat

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Therapeutic drug monitoring of clozapine treatment. Therapeutic threshold value for serum clozapine concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Olanzapine Serum Concentrations in Psychiatric Patients Given Standard Doses: The Influence of Comedication

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Olanzapine increases weight and serum triglyceride levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Bodyweight change as an adverse effect of drug treatment. Mechanisms and management

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Changes in weight in patients receiving a tranquilizing drug

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Chronic treatment with antipsychotics in rats as a model for antipsychotic-induced weight gain in human

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Tolerability and therapeutic effect of clozapine. A retrospective investigation of 216 patients treated with clozapine for up to 12 years

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Activation of MEK/ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor gamma (PPARgamma ) and C/EBPalpha gene expression during the differentiation of 3T3-L1 preadipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Metabolic fuel selection: general integration at the whole-body level

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Polymorphism of the promoter region of the serotonin 5-HT(2C) receptor gene and clozapine-induced weight gain

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Efficacy and side-effects of clozapine not associated with variation in the 5-HT2C receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Bodyweight gain associated with atypical antipsychotics: epidemiology and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Roles of 5'-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Glucose sensing in pancreatic beta-cells: a model for the study of other glucose-regulated cells in gut, pancreas, and hypothalamus

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Is the energy homeostasis system inherently biased toward weight gain?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Glucose tolerance in chronic schizophrenia and senile states.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

GLUT4 heterozygous knockout mice develop muscle insulin resistance and diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Targeted disruption of the beta 3-adrenergic receptor gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Food and metabolic signalling defects in a Caenorhabditis elegans serotonin-synthesis mutant

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Targeted disruption of H3 receptors results in changes in brain histamine tone leading to an obese phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Insights into alpha1 adrenoceptor function in health and disease from transgenic animal studies

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Prevalence of obesity in adolescent and young adult patients with and without schizophrenia and in relationship to antipsychotic medication

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Behavioral characterization of mice lacking histamine H(3) receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

-759C/T genetic variation of 5HT(2C) receptor and clozapine-induced weight gain

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

The relationship between serum concentration and therapeutic effect of haloperidol in patients with acute schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

A Survey for Unknown Diabetics in a Mental Hospital: II. Men from Age Fifty

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Distribution of clozapine and desmethylclozapine between blood and brain in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Weight gain: side effect of atypical neuroleptics?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

The effects of novel antipsychotics on glucose and lipid levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Physiological functions of the pentose phosphate pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Characterization of inhibition by risperidone of the inwardly rectifying K(+) current in pituitary GH(3) cells

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

An mRNA splice variant of the AFX gene with altered transcriptional activity

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

The effect of clozapine on glucose metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Effects of clozapine on behavioral and metabolic traits relevant for schizophrenia in two mouse strains

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Effects of antipsychotics on fat deposition and changes in leptin and insulin levels. Magnetic resonance imaging study of previously untreated people with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

Insulin resistance and increased leptin concentrations in noncompliant schizophrenia patients but not in antipsychotic-naive first-episode schizophrenia patients

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965008-2

7 January 2021

10.1016/S0074-7742(04)65008-2

Identifiers

DOI

1 reference

13 August 2017

1 reference